Ridaforolimus in Treatment of Sarcoma-SUCCEED (Sarcoma Multi-Center Clinical Evaluation of the Efficacy of Ridaforolimus)(8669-011 AM6)

Clinical trial NCT00538239 · COMPLETED

Trial details

NCT number: NCT00538239
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Soft-Tissue Sarcomas Metastatic Bone Sarcomas

Start date: 2007-10-01
Primary completion: 2010-10-01
Enrollment: 711

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.